To further explore whether the Nrf2/Keap1/ARE signaling pathways are the underlying mechanism for CBD-mediated protective effects in OM, HOK cells were treated with ML385 (an inhibitor of Nrf2). The gene discussed is KEAP1; the disease is ocular melanoma.